Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed? (scientific article published on 9 December 2013)

Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.

Q31019080

External review and validation of the Swedish national inpatient register

Q33928068

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

Q34130671

Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry

Q34249182

Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review

Q34574374

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness

Q34574857

Swedish registers to examine drug safety and clinical issues in RA.

Q35637262

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

Q35637894

Systematic review of studies of productivity loss due to rheumatoid arthritis

Q36312507

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

Q37710906

The burden of illness of rheumatoid arthritis

Q37848120

Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden

Q40189868

Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration

Q44545230

The burden of rheumatoid arthritis and access to treatment: health burden and costs

Q46256192

Societal cost of rheumatoid arthritis patients in the US.

Q48956161

Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.

Q50732154

How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?

Q51160559

The friction cost method for measuring indirect costs of disease.

Q53643490

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

rheumatoid arthritis

Q187255

P304

page(s)

648-654

P577

publication date

2013-12-09

P1433

published in

Annals of the Rheumatic Diseases

Q4767876

P1476

title

Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?

P478

volume

Reverse relations

cites work (P2860)

Q91752751	Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage
Q38645102	Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis
Q39829013	Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis
Q38907286	Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators
Q38410704	Does disease activity at start of biologic therapy influence work-loss in RA patients?
Q30984829	Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data
Q53691372	Effects of aerobic and resistance exercise in older adults with rheumatoid arthritis: A randomized controlled trial.
Q56794417	Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review
Q48508515	Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study.
Q39888893	Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.
Q37662723	Non-medical costs during the first year after diagnosis in two cohorts of patients with early rheumatoid arthritis, enrolled 10 years apart
Q40015472	Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996-98 and 2006-09.
Q48075422	The burden of disease in rheumatoid arthritis
Q35043018	The high frequency of healthcare use in patients one year prior to a sarcoidosis diagnosis.
Q99608910	The relationship between dietary patterns and rheumatoid arthritis: a case-control study
Q90472489	Use of Rheumatologic Testing in Patients Who Eventually Receive a Diagnosis of Rheumatoid Arthritis

P356	DOI	10.1136/ANNRHEUMDIS-2013-204080
P698	PubMed publication ID	24323395